Picture of Sinphar Pharmaceutical Co logo

1734 Sinphar Pharmaceutical Co Balance Sheet

0.000.00%
tw flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Sinphar Pharmaceutical Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments9758861,1941,2451,244
Net Total Accounts Receivable
Net Total Receivables572635469593685
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets2,1222,2622,5402,7032,778
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment3,3843,3523,3213,2473,204
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets5,8785,9176,1276,2216,185
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities8891,1561,3301,5341,446
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities2,9523,1333,3823,4993,255
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity2,9262,7832,7442,7222,930
Total Liabilities & Shareholders' Equity5,8785,9176,1276,2216,185
Total Common Shares Outstanding